Mark Kleinman: FCA is naming and shaming itself, not the City February 20, 2025 Mark Kleinman is Sky News’ City Editor and the man who gets the Square Mile talking in his weekly City AM column. Today, he tackles name and shame at the FCA, a gamble at Entain and a business group revamp FCA is naming and shaming itself, not the City It’s rare to get a consensus this strong – but [...]
Mark Kleinman: Bonfire of the regulators just beginning February 13, 2025 Mark Kleinman is Sky News’ City Editor and the man who gets the Square Mile talking in his weekly City AM column. This week, he tackles churn at the regulators, bankers’ bonuses and dilemmas at Deliveroo. Bonfire of the regulators is just beginning For Marcus Bokkerink, read Abby Thomas? The chief executive of the Financial Ombudsman Service last [...]
Mark Kleinman: NatWest staff set for Valentine’s Day bonus February 6, 2025 Mark Kleinman is Sky News’ City Editor and the man who gets the Square Mile talking in his weekly City AM column. This week, he tackles a love-in at NatWest, a Budget blow to private healthcare and how cricket went all out NatWest staff set for Valentine’s Day bonus The finishing line is in sight. NatWest’s journey through [...]
Mark Kleinman: Are Barclays pay rows a mere historical relic? January 30, 2025 Mark Kleinman is Sky News’ City Editor and the man who gets the Square Mile talking in his weekly City AM column. This week, he tackles pay rows at Barclays, how WH Smith is clinging on and a floating debate for Monzo Are Barclays pay rows a mere historical relic? There was a time when Barclays and public [...]
Mark Kleinman: Kicking the Abbey habit may be harder than it looks for Botin January 23, 2025 Mark Kleinman is Sky News’ City Editor and the man who gets the Square Mile talking in his weekly City AM column. This week, he looks at Santander shifts, a tale of two cities in banking and a canary in the Poundland coalmine Kicking the Abbey habit may be harder than it looks for Botin Is this the [...]
Mark Kleinman: Regulators’ D-Day is crucial for Starmer agenda January 16, 2025 Mark Kleinman is Sky News’ City Editor and is the man who gets the Square Mile talking in his weekly City AM column. This week, he looks at D-Day for regulators, Ebury’s IPO knife-edge and Badenoch’s Reform nightmare Regulators’ D-Day is crucial for Starmer agenda It’s D-Day for Britain’s regulators. Barely three weeks after a dozen economic watchdogs were [...]
Mark Kleinman: Ratcliffe’s cost-cutting results in Manchester Disunited January 9, 2025 Mark Kleinman is Sky News’ City Editor and is the man who gets the Square Mile talking in his weekly City AM column. This week, he tackles Ratcliffe’s own goal, Shawbrook setting the tone and a FTSE 100 Doomsday clash over pay Ratcliffe’s cost-cutting results in Manchester Disunited Sir Jim Ratcliffe might not like to admit it, but 2024 [...]
Thames Water to avoid state bailout, the FTSE 100 at 7900 and an ITV bid: my predictions for UK plc in 2025 January 2, 2025 Predictions may generally be a mug’s game, but looking back at my forecasts for the business world in 2024, I seem to have fared better than usual. Klarna, the buy now pay later giant, opted for a New York listing; Dame Alison Rose made a comeback in a senior private equity role; Unilever announced that [...]
Mark Kleinman: Hold the Telegraph front page – then hold it some more December 27, 2024 Mark Kleinman is Sky News’ City Editor and is the man who gets the Square Mile talking in his weekly City AM column. This week he tackles the Telegraph bid, Mike Ashley’s failed Boohoo approach and an oil deal in the North Sea I suspect you’d have got long odds on January 1 on the auction of The Daily [...]
Mark Kleinman: Boots’ dealmaker tries to formulate new potion December 19, 2024 Mark Kleinman is Sky News’ City Editor and is the man who gets the Square Mile talking in his weekly City AM column. This week, he tackles buyouts at Boots, big bonuses at Natwest and Reeves’ China charm offensive Boots’ octogenarian dealmaker tries to formulate new potion If life begins at 80, then Stefano Pessina, the octogenarian pharmaceuticals [...]
